NCT02986724View on ClinicalTrials.gov

A Study to Observe the Safety and Efficacy of Vedolizumab in Biologically Naive Participants With Ulcerative Colitis (UC) or Crohn´s Disease (CD)

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

January 4, 2017

Primary Completion Date

August 31, 2020

Study Completion Date

August 31, 2020

Conditions
Crohn DiseaseColitis, UlcerativeInflammatory Bowel Diseases
Trial Locations (1)

Unknown

Innsbruck

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY